1. Home
  2. PKOH vs STRO Comparison

PKOH vs STRO Comparison

Compare PKOH & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park-Ohio Holdings Corp.

PKOH

Park-Ohio Holdings Corp.

HOLD

Current Price

$24.34

Market Cap

299.5M

Sector

Industrials

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$24.39

Market Cap

338.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKOH
STRO
Founded
1907
2003
Country
United States
United States
Employees
N/A
131
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
299.5M
338.9M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
PKOH
STRO
Price
$24.34
$24.39
Analyst Decision
Buy
Buy
Analyst Count
1
8
Target Price
$37.00
$26.38
AVG Volume (30 Days)
26.7K
167.1K
Earning Date
03-04-2026
03-23-2026
Dividend Yield
2.06%
N/A
EPS Growth
N/A
N/A
EPS
1.70
N/A
Revenue
$1,599,100,000.00
N/A
Revenue This Year
$7.87
N/A
Revenue Next Year
$3.42
$13.45
P/E Ratio
$14.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.52
$0.52
52 Week High
$29.50
$27.96

Technical Indicators

Market Signals
Indicator
PKOH
STRO
Relative Strength Index (RSI) 44.99 63.05
Support Level $23.71 $0.76
Resistance Level $29.00 $27.96
Average True Range (ATR) 1.12 2.27
MACD -0.09 -0.14
Stochastic Oscillator 58.54 61.34

Price Performance

Historical Comparison
PKOH
STRO

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: